Free Trial

Aurinia Pharmaceuticals (AUPH) Insider Trading & Ownership

Aurinia Pharmaceuticals logo
$16.25 +0.21 (+1.31%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$16.25 0.00 (-0.02%)
As of 05:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aurinia Pharmaceuticals (NASDAQ:AUPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$20.81M
Number Of
Insiders Selling
(Last 12 Months)
0
Get AUPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aurinia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AUPH Insider Buying and Selling by Quarter

Aurinia Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2026
Kevin Tang
Director
Buy516,439$13.99$7,224,981.61  
8/5/2025
Kevin Tang
Director
Buy200,000$11.68$2,336,000.00  
8/4/2025
Kevin Tang
Director
Buy100,000$11.34$1,134,000.00  
8/1/2025
Kevin Tang
Director
Buy1,000,000$10.12$10,120,000.00  
(Data available from 1/1/2013 forward)

AUPH Insider Trading Activity - Frequently Asked Questions

12.20% of Aurinia Pharmaceuticals stock is owned by insiders. Learn more on AUPH's insider holdings.

The following insider purchased AUPH shares in the last 24 months: Kevin Tang ($20,814,981.61).

Insiders have purchased a total of 1,816,439 AUPH shares in the last 24 months for a total of $20,814,981.61 bought.

The following insiders have sold AUPH shares in the last 24 months: Greg Keenan ($166,262.15), Jeffrey Allen Bailey ($38,415.51), Joseph M Miller ($494,872.00), Matthew Maxwell Donley ($527,216.00), Peter Greenleaf ($1,564,744.00), and Scott Michael Habig ($96,902.19).

Insiders have sold a total of 366,704 Aurinia Pharmaceuticals shares in the last 24 months for a total of $2,888,411.85 sold.



This page (NASDAQ:AUPH) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners